p16(INK4a) and the control of cellular proliferative life span

Carcinogenesis

Volumn 20, Issue 6, 1999, Pages 921-926

  Huschtscha, Lily I ^a   Reddel, Roger R ^a  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; TELOMERASE;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL DIVISION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GENE FUNCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENESCENCE; SOMATIC CELL; TUMOR SUPPRESSOR GENE;

CELL AGING; CELL DIVISION; CELL LINE, TRANSFORMED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0033049828     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.6.921     Document Type: Article

References (94)

1. Hayflick, L. and Moorhead, P.S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res., 25, 585-621.
2. Reddel, R. (1998) A reassessment of the telomere hypothesis of senescence. BioEssays, 20, 977-984.
3. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev., 8, 2540-2551.
4. Chen, Q. and Ames, B.N. (1994) Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl Acad. Sci. USA, 91, 4130-4134.
5. Von Zglinicki, T., Saretzki, G., Döcke, W. and Lotze, C. (1995) Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: A model for senescence? Exp. Cell Res., 220, 186-193.
6. Chen, Q., Fischer, A., Reagan, J.D., Yan, L.-J. and Ames, B.N. (1995) Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl Acad. Sci. USA. 92, 4337-4341.
7. 2: Senescence-like growth arrest or apoptosis? Cell Growth Differ., 8, 589-598.
8. Hicks, G.G., Egan, S.E., Greenberg, A.H. and Mowat, M. (1991) Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest. Mol. Cell. Biol., 11, 1344-1352.
9. INK4a. Cell, 88, 593-602.
10. Zhu, J., Woods, D., McMahon, M. and Bishop, J.M. (1998) Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev., 12, 2997-3007.
11. Sager, R. (1991) Senescence as a mode of tumor suppression. Environ. Health Perspect., 93, 59-62.
12. Campisi, J. (1997) The biology of replicative senescence. Eur. J. Cancer, 33A, 703-709.
13. Cristofalo, V.J. and Pignolo, R.J. (1996) Molecular markers of senescence in fibroblast-like cultures. Exp. Gerontol., 31, 111-123.
14. CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol., 16, 859-867.
15. INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene, 15, 495-503.
16. Alcorta, D.A., Xiong, Y., Phelps, D., Hannon, G., Beach, D. and Barrett, J.C. (1996) Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl Acad. Sci. USA, 93, 13742-13747.
17. Reznikoff, C.A., Yeager, T.R., Belair, C.D., Savelieva, E., Puthenveettil, J.A. and Stadler, W.M. (1996) Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res., 56, 2886-2890.
18. INK4A with human head and neck keratinocyte replicative senescence: Relationship of dysfunction to immortality and neoplasia. Oncogene, 13, 561-568.
19. Erickson, S., Sangfelt, O., Heyman, M., Castro, J., Einhorn, S. and Grandér, D. (1998) Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence. Oncogene, 17, 595-602.
20. INK4 in human cancer. Proc. Natl Acad. Sci. USA, 91, 11045-11049.
21. INK4 and telomerase in immortalisation of human cells. Oncogene, 11, 971-976.
22. INK4 expression. Oncogene, 13, 1259-1268.
23. CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ., 9, 139-146.
24. Brenner, A.J. and Aldaz, C.M. (1995) Chromosome 9p allelic loss and p16/ CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res., 55, 2892-2895.
25. Yeager, T., Stadler, W., Belair, C., Puthenveettil, J., Olopade, O. and Reznikoff, C. (1995) Increased p16 levels correlate with pRB alterations in human urothelial cells. Cancer Res., 55, 493-497.
26. Girardi, A.J., Jensen, F.C. and Koprowski, H. (1965) SV40-induced transformation of human diploid cells: Crisis and recovery. J. Cell. Comp. Physiol., 65, 69-84.
27. Huschtscha, L.I. and Holliday, R. (1983) Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts. J. Cell. Sci., 63, 77-99.
28. Shay, J.W. and Wright, W.E. (1989) Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp. Cell Res., 184, 109-118.
29. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B. and Bacchetti, S. (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11, 1921-1929.
30. Counter, C.M., Botelho, F.M., Wang, P., Harley, C.B. and Bacchetti, S. (1994) Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol., 68, 3410-3414.
31. Klingelhutz, A.J., Barber, S.A., Smith, P.P., Dyer, K. and McDougall, J.K. (1994) Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol. Cell. Biol., 14, 961-969.
32. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S. and Reddel, R.R. (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J., 14, 4240-4248.
33. Bryan, T.M. and Reddel, R.R. (1994) SV40-induced immortalization of human cells. Crit. Rev. Oncog., 5, 331-357.
34. Shay, J.W. and Bacchetti, S. (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer, 33A, 787-791.
35. Bryan, J.M., Englezou, A., Dalla-Pozza, L., Dunham, M.A. and Reddel, R.R. (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med., 3, 1271-1274.
36. Rotter, V. and Prokocimer, M. (1991) p53 and human malignancies. Adv. Cancer Res., 57, 257-272.
37. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
38. Wynford-Thomas, D. (1996) p53: Guardian of cellular senescence. J. Pathol., 180, 118-121.
39. ARF, Cell, 91, 555-558.
40. Quelle, D.E., Zindy, F., Ashmun, R.A. and Sherr, C.J. (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83, 993-1000.
41. Duro, D., Bemard, O., Della Valle, V., Berger, R. and Larsen, C.J. (1995) A new type of p161NK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene, 11, 21-29.
42. INK4A transcript. Cancer Res., 55, 2995-2997.
43. Stone, S., Jiang, P., Dayananth, P., Tavtigian, S.V., Katcher, H., Parry, D., Peters, G. and Kamb, A. (1995) Complex structure and regulation of the P16 (MTS1) locus. Cancer Res., 55, 2988-2994.
44. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J., 17, 5001-5014.
45. ARF. Cell, 91, 649-659.
46. Jacobs, J.J.L., Kieboom, K., Marino, S., DePinho, R.A. and van Lohuizen, M. (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature, 397, 164-168.
47. Ludlow, J.W., Glendening, C.L., Livingston, D.M. and DeCaprio, J.A. (1993) Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol., 13, 367-372.
48. Sherr, C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677.
49. Serrano, M., Hannon, G.J. and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707.
50. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-261.
51. Hirai, H., Roussel, M.F., Kato, J.-Y., Ashmun, R.A. and Sherr, C.J. (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15, 2672-2681.
52. CDKN2/INK4A. Curr. Biol., 6, 84-91.
53. INK4a. Nature, 395, 237-243.
54. INK4d. Nature, 395, 244-250.
55. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harchman, K., Tavtigian, S.V., Stockert, E., Day, R.S. III, Johnson, B.E. and Skolnick, M.H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
56. INK4 mutations and altered expression in human tumors and cell lines. Cold Spring Harb. Symp. Quant. Biol., 59, 49-58.
57. Liggett, W.H. Jr and Sidransky, D. (1998) Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol. 16, 1197-1206.
58. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P.J., Davidson, N.E., Sidransky, D. and Baylin, S.B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.
59. INK4 expression in primary lung cancers and cell lines. Cancer Res., 55, 505-509.
60. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p 16/ CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692.
61. Mori, T., Miura, K., Aoki, T., Nishihira, J., Mori, S. and Nakamura, Y. (1994) Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/ cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54, 3396-3397.
62. Caldas, C., Hahn, S.A., Da Costa, L.T., Redston, M.S., Schutte, M., Seymour, A.B., Weinstein, C.L., Hruban, R.H., Yeo, C.J. and Kern, S.E. (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet., 8, 27-32.
63. INK4A: Structural characterization of wild-type and mutant proteins by NMR and circular dichroism. Biochemistry, 35, 9475-9487.
64. INK4 proteins encoded by tumor-derived alleles. J. Biol. Chem., 271, 28734-28737.
65. Hussussian, C.J., Struewing, J.P., Goldstein, A.M., Higgins, P.A., Ally, D.S., Sheahan, M.D., Clark, W.H. Jr, Tucker, M.A. and Dracopoli, N.C. (1994) Germline p16 mutations in familial melanoma. Nature Genet., 8, 15-21.
66. INK4 gene in Australian melanoma kindreds. Hum. Mol. Genet., 4, 1845-1852.
67. Gruis, N.A., Van der Velden, P.A., Sandkuijl, L.A., Prins, D.E., Weaver-Feldhaus, J., Kamb, A., Bergman, W. and Frants, R.R. (1995) Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature Genet., 10, 351-353.
68. Holland, E.A., Beaton, S.C., Becker, T.M., Grulet, O.M.C., Peters, B.A., Rizos, H., Kefford, R.F. and Mann, G.J. (1995) Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene, 11, 2289-2294.
69. INK4 mutations. N. Engl. J. Med., 333, 970-974.
70. Ink4B/MTS2 genes in biliary tract cancers. Cancer Res., 55, 2756-2760.
71. INK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma. Hepatology, 25, 1376-1381.
72. Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D. and DePinho, R.A. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85, 27-37.
73. INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol., 15, 4745-4753.
74. Maclean, K., Rogan, E.M., Whitaker, N.J., Chang, A.C.-M., Rowe, P.B., Dalla-Pozza, L., Symonds, G. and Reddel, R.R. (1994) In vitro transformation of Li-Fraumeni syndrome fibroblasts by SV40 large T antigen mutants. Oncogene, 9, 719-725.
75. Brenner, A.J., Stampfer, M.R. and Aldaz, C.M. (1998) Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene, 17, 199-205.
76. Foster, S.A., Wong, D.J., Barrett, M.T. and Galloway, D.A. (1998) Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol., 18, 1793-1801.
77. INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res., 58, 3508-3512.
78. Stampfer, M.R. and Bartley, J.C. (1985) Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc. Natl Acad. Sci. USA, 82, 2394-2398.
79. Stampfer, M.R. (1985) Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods, 9, 107-115.
80. Foster, S.A. and Galloway, D.A. (1996) Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene, 12, 1773-1779.
81. Wazer, D.E., Liu, X.-L., Chu, Q., Gao, Q. and Band, V. (1995) Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc. Natl Acad. Sci. USA, 92, 3687-3691.
82. Olovnikov, A.M. (1973) A theory of marginotomy, J. Theor. Biol., 41, 181-190.
83. Harley, C.B., Vaziri, H., Counter, C.M. and Allsopp, R.C. (1992) The telomere hypothesis of cellular aging. Exp. Gerontol., 27, 375-382.
84. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.-P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S. and Wright, W.E. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349-352.
85. Vaziri, H. and Benchimol, S. (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol., 8, 279-282.
86. Morales, C.P., Holt, S.E., Ouellette, M., Kaur, K.J., Van, Y., Wilson, K.S., White, M.A., Wright, W.E. and Shay, J.W. (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet., 21, 115-118.
87. Jiang, X.-R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A.G., Wahl, G.M., Tlsty, T.D. and Chiu, C.-P. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature Genet., 21, 111-114.
88. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature, 396, 84-88.
89. Lin, A.W., Barradas, M., Stone, J.C., Van Aelst, L., Serrano, M. and Lowe, S.W. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev., 12, 3008-3019.
90. Marshall, C.J. (1994) MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev., 4, 82-89.
91. INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene, 16, 1113-1123.
92. McConnell, B.B., Starborg, M., Brookes, S. and Peters, G. (1998) Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol., 8, 351-354.
93. Dimri, G.P., Lee, X.H., Basile, G., Acosta, M., Scott, C., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., Pereira-Smith, O., Peacocke, M. and Campisi, J. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA, 92, 9363-9367.
94. INK4-and p18-containing complexes in human cell lines. J. Biol. Chem., 271, 15942-15949.